Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-14

Clinical Trial Update: Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of intralesional triamcinolone combined with 8% topical pirfenidone for treating keloid scars. The current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)
  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Centro Dermatológico Dr. Ladislao de la Pascua | Conditions: Keloid | Phase 3 | Status: UNKNOWN